News und Analysen
AEVIS VICTORIA SA - Swiss Medical Network publishes 2024 results and confirms the strength of its integrated care model
AEVIS VICTORIA SA - Swiss Medical Network publishes 2024 results and confirms the strength of its integrated care model
Secure, Efficient and Trusted: Axelera AI and Kudelski IoT Partner for Next Generation Edge Intelligent Ecosystem
Secure, Efficient and Trusted: Axelera AI and Kudelski IoT
Partner for Next Generation Edge Intelligent Ecosystem
Kudelski IoT and u-blox collaborate to bring advanced security to autonomous driving, drones and agricultural applications
Kudelski IoT and u-blox collaborate to bring advanced security to autonomous driving, drones and agricultural applications
AEVIS VICTORIA SA – Strong growth in 2024 revenue and improved profitability
AEVIS VICTORIA SA – Strong growth in 2024 revenue and improved profitability
2024 ANNUAL RESULTS
2024 ANNUAL RESULTS
The Kudelski Group announces transformation and cost reductions
The Kudelski Group announces transformation
and cost reductions
RecovR ID Check: Protecting Automotive Dealers Against Fraud and Identity Theft
RecovR ID Check: Protecting Automotive Dealers Against Fraud and Identity Theft
Unlocking Efficiency and Reducing Loss: Kudelski IoT’s RecovR and KEYper Systems Team Up to Revolutionize Dealership Key Management in Automotive Retail
Unlocking Efficiency and Reducing Loss: Kudelski IoT’s RecovR and KEYper Systems Team Up to Revolutionize Dealership Key Management in Automotive Retail
Change in leadership structure at NAGRAVISION
Change in leadership structure at NAGRAVISION
Rieter: Update on the Completion of the Acquisition of Barmag Ad-hoc announcement pursuant to Art. 53 LR
Rieter: Update on the Completion of the Acquisition of Barmag
Ad-hoc announcement pursuant to Art. 53 LR
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
SIX Exchange Regulation approves delisting of u-blox registered shares and grants exemption from specific disclosure requirements
SIX Exchange Regulation approves delisting of u-blox registered shares and grants exemption from specific disclosure requirements
Key Figures 15.12.2025
Key Figures
15.12.2025
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
HBM Healthcare Investments Announces Agreement to Sell Majority of Investment in Swixx Biopharma
HBM Healthcare Investments Announces Agreement to Sell Majority of Investment in Swixx Biopharma
HUBER+SUHNER updates guidance for 2025
HUBER+SUHNER updates guidance for 2025
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
u-blox launches SIG 2.00 GNSS firmware: 95%-confidence geolocation for Wi-Fi 6E/7/8 access points
u-blox launches SIG 2.00 GNSS firmware: 95%-confidence geolocation for Wi-Fi 6E/7/8 access points
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Cicor revises 2025 full-year guidance due to lower demand in Germany and adverse currency fluctuation while A&D related order intake remains strong
Cicor revises 2025 full-year guidance due to lower demand in Germany and adverse currency fluctuation while A&D related order intake remains strong
Bystronic nominates Daniel Bischofberger and Fabrice Billard for election to the Board of Directors
Bystronic nominates Daniel Bischofberger and Fabrice Billard for election to the Board of Directors
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
u-blox introduces JODY-B1, the automotive Bluetooth module enabling multiple simultaneous connections
u-blox introduces JODY-B1, the automotive Bluetooth module enabling multiple simultaneous connections
Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million
Mirum Pharmaceuticals to acquire HBM portfolio company Bluejay Therapeutics for up to USD 820 million


